Actos Recall Instant

: Following a 2011 French study linking the drug to bladder cancer, medical authorities in France and Germany suspended or banned the use of Actos.

While there have been significant legal and international developments, it is important to clarify that . ACTOS RECALL

: In June 2011, the FDA issued a safety communication warning that using Actos for more than one year may increase the risk of bladder cancer by 40%. : Following a 2011 French study linking the

However, the drug has faced bans in other countries and intense legal scrutiny due to serious health concerns. Key Safety Warnings and Bans However, the drug has faced bans in other

: The FDA requires a "black box" warning—its strongest level—on the product label to alert patients to the risk of congestive heart failure . Major Legal Settlements

Takeda Pharmaceuticals , the manufacturer, has faced thousands of lawsuits from patients alleging they were not properly warned about the risk of bladder cancer. Actos Recall in the U.S. | Girard Gibbs LLP